Physician profile
David Jones
NPI 1336132430
$539,704.41
in general payments reported to CMS, 2019-2025
33 companies · $87K in 2025
The $87K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $79K · 2021: $95K · 2022: $107K · 2023: $85K · 2024: $86K · 2025: $87K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $247K · Consulting Fee: $9,000 · Travel and Lodging: $1,105 · Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $247,277.82 |
| Consulting Fee | $9,000.00 |
| Travel and Lodging | $1,104.79 |
| Food and Beverage | $1,036.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $537,229.48 | 2020-2025 | Identiti, Other - Miscellaneous, Invictus Mis |
| Boston Scientific Corporation | $667.29 | 2019-2025 | Wavewriter Alpha Prime 16, Fathom -16, General - Pain Management |
| Arbor Pharmaceuticals, INC. | $282.22 | 2019-2022 | |
| Stryker Corporation | $209.16 | 2019-2025 | Omnicurve, Mild Device Kit |
| Providence Medical Technology, INC. | $201.53 | 2023-2024 | |
| Ethicon US, LLC | $128.14 | 2023-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Evarrest |
| Globus Medical, INC. | $100.20 | 2023 | Elsa, Elsa Al/Atp |
| Intrinsic Therapeutics | $82.00 | 2021 | |
| Si-Bone, INC. | $75.24 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $65.76 | 2022-2023 | Xtampza |
| Biedermann Motech, INC. | $60.95 | 2019 | |
| Zyla Life Sciences, INC. | $57.01 | 2019 | |
| Amgen INC. | $48.52 | 2024 | Evenity, Prolia |
| Redhill Biopharma INC. | $44.66 | 2020-2021 | |
| Saluda Medical Americas, INC. | $43.86 | 2023 | Evoke Scs |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $40.87 | 2023-2024 | Intellis Adaptivestim, Aquamantys(Tm) |
| Vertex Pharmaceuticals Incorporated | $37.03 | 2025 | |
| Baxter Healthcare | $36.58 | 2020 | |
| Integra Lifesciences Corporation | $33.49 | 2022-2024 | Instruments-Orthopedic, Microfrance, Integra Duo |
| Theragen, INC. | $31.30 | 2023 | Actastim-S |
| Medtronic USA, INC. | $29.05 | 2019 | |
| Spineology INC. | $26.07 | 2020 | |
| Heron Therapeutics, INC. | $24.64 | 2024 | Zynrelef |
| Spinal Simplicity, LLC | $23.86 | 2022 | |
| Spine Wave, INC. | $23.79 | 2025 | Spinal Implant |
| Bioventus LLC | $21.51 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.85 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.45 | 2023 | Relistor |
| Allergan, INC. | $12.51 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.65 | 2022 | |
| Wound Management Technologies, INC | $10.86 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.